16 November 2010
Anasarca and chylous effusions: An unusual presentation of systemic amyloidosis
Maureen R. HortonAm J Case Rep 2010; 11:191-194 :: ID: 881255
Abstract
Background: Amyloidosis is the result of pathologic deposition of insoluble fibrilar proteins in normal tissues. The resultant accumulation of proteins leads to a wide array of seeming unconnected organ dysfunctions and symptoms often delaying diagnosis.
Case Report: We present a case of primary systemic amyloidosis presenting as anasarca and chylous effusions in a 63 year old man with a past medical history of hypertension and obstructive sleep apnea. The patient noted the onset of anasarca, dyspnea on exertion in the setting of a 50-pound weight loss over 6 months. Through evaluation revealed anasarca, chylous pleural and peritoneal effusions, tachypnea and dyspnea on exertion. Laboratories were unremarkable except for an elevated ESR of 30 and BUN/Cr of 27/1.6 with a bland urinalysis. Chest imaging revealed bilateral pleural effusions with compressive atelectasis and lymphoscintigraphy revealed normal lymphatic flow with no thoracic duct leak. Due to concerns for constrictive pericarditis, the patient underwent a right heart catheterization that was not consistent with pericardial disease. However, endomyocardial biopsy revealed cardiac amyloidosis. Further evaluation revealed elevated free serum Kappa light chains with an elevated free Kappa/Lambda ratio.
Conclusions: We present an atypical presentation of a rare disease, primary AL amyloidosis. Although large pleural effusions are rare in amyloidosis, they are usually exudative and may be due to direct pleural infiltration or amyloid–induced heart, liver, renal or thyroid failure. Thus, large pleural effusions, especially chylous, without clear etiology should raise the suspicion for amyloidosis and lead to further investigations.
Keywords: chylous , anasarca, Amyloidosis
SARS-CoV-2/COVID-19
22 February 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938732
22 February 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938761
16 March 2023 : Case report
Am J Case Rep 2023; 24:e938359
01 March 2023 : Case report
Am J Case Rep 2023; 24:e937955
In Press
17 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939411
17 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939474
16 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938752
15 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938875
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347